ArticleFrontiers in oncology2026
Ultrasound deep learning features for predicting cervical lymph node metastasis in papillary thyroid carcinoma.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The purpose of this study was to create and validate a clinical deep learning radiomics (DLR) model for determining cervical lymph node metastasis (CLNM) status in patients with papillary thyroid cancer (PTC). Methods: A total of 205 eligible patients with PTC who underwent preoperative thyroid ultrasonography (US) between January 2015 and April 2020 were retrospectively enrolled. The training cohort consisted of 143 patients, while the validation cohort included 62 patients. A DLR model was built using deep learning features, a clinical model was built using clinical parameters, and a Cli-DLR model was built using both DLR features and clinical factors. Results: In the validation cohort, the Cli-DLR model performed well, with an AUC of 0.80. The Cli-DLR model performed well in terms of precision-recall and calibration curve analysis. Furthermore, the Cli-DLR model outperformed experienced radiologists. This approach has the potential to help guide optimal CLNM management in PTC patients, particularly by preventing overtreatment. Conclusions: In conclusion, we developed a Cli-DLR model to assess the cervical lymph node status of PTC patients prior to surgery. The Cli-DLR model outperformed radiologists and the clinical model. Consequently, this model can provide a possible noninvasive method for detecting CLNM and aid in clinical decision-making due to its favorable specificity and sensitivity. High-level evidence for clinical use in later studies is anticipated to be obtained through prospective multicenter validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.